Ardelyx

These 5 Biotech Stocks Under $10 Are About to Break Out
TheStreet.com
Fri, 04/1/16 - 09:23 am
biotech
Ardelyx
Biocryst
Affimed
Adaptimmune
Sangamo BioSciences
8 Biotech Stocks That Have a ‘Greater Probability’ of Being Acquired
Barron's
Tue, 03/29/16 - 12:24 pm
biotech
M&A
Ardelyx
Ophthotech
Medivation
Puma Biotechnology
Ultragenyx
Portola Pharmaceuticals
Versartis
Relypsa
4 Ignored Biotech Stocks for 2016
24/7 Wall St
Wed, 12/23/15 - 11:08 am
ANI Pharmaceuticals
Corbus Pharmaceuticals
Geron
Ardelyx
Who Could Be Allergan PLC Next Acquisition Target?
Bidness, ETC
Thu, 08/20/15 - 09:00 am
Allergan
M&A
Pfenex
Ligand Pharmaceuticals
Ardelyx
AstraZeneca partner Ardelyx plunges after citing safety issue for lead drug
Fierce Biotech
Mon, 02/2/15 - 03:21 pm
AstraZeneca
Ardelyx
tenapanor
IBS
Ardelyx irritable bowel syndrome drug succeeds in mid-stage trial
Reuters
Wed, 10/1/14 - 08:19 am
Ardelyx
IBS
irritable bowel syndrome
tenapanor
AstraZeneca Pharma India
IPO Preview: Ardelyx (ARDX)
Seeking Alpha
Thu, 06/19/14 - 08:53 am
IPOs
Ardelyx
Sanofi
AstraZeneca
Ardelyx licenses NaP2b phosphate inhibitor program to Sanofi
Yahoo/Fly on the Wall
Mon, 02/24/14 - 09:57 am
Sanofi
Ardelyx
NaP2b phosphate inhibitor
AstraZeneca bags license to Ardelyx kidney drugs
Pharma Times, UK
Mon, 10/8/12 - 12:14 pm
AstraZeneca
Ardelyx
NHE3 inhibitors

Pages